LIGANDAL INC has a total of 28 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and micro-structure and nano-technology are PULIKE BIOLOGICAL ENG INC, GENETHOR GMBH and CRUCELL SWITZERLAND AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Australia | 4 | |
#4 | Canada | 4 | |
#5 | EPO (European Patent Office) | 4 | |
#6 | China | 2 | |
#7 | Israel | 2 | |
#8 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Micro-structure and nano-technology | |
#4 | Measurement | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Nanostructure applications | |
#5 | Peptides | |
#6 | Combinatorial chemistry | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Watson Andre Ronald | 26 |
#2 | Foster Christian | 26 |
#3 | Lin Shuailiang | 11 |
#4 | Peyrot Sara Marie | 6 |
#5 | Spencer Ryan | 1 |
#6 | Connors William | 1 |
#7 | Dobbin Matthew | 1 |
#8 | Chizari Shahab | 1 |
#9 | Deshpande Pranali | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020223705A2 | Methods and compositions for diagnostically-responsive ligand-targeted delivery of therapeutic agents | |
CA3098382A1 | Methods and compositions for genome editing | |
US2020208177A1 | Methods and compositions for genome editing | |
CN110582301A | Methods and compositions for nucleic acid and protein payload delivery |